IPIC Message Board - Msg: 2260009

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Dec 18 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Ryan who wrote (721)	9/23/1997 6:32:00 PM
From: Pancho Villa	of 1359

Wow, that is what I call real "burning". It seems quite high (about $300,000/employee) for a company with no in-house/capital intensive R&D. Hopefully they won't waste any of it supporting the price of the stock or doing excesive PR or they will run out of cash before a year's time. I think I have reached my own conclusion: I will consider getting in at around 6-7, if it looks like they can make peace with the FDA folks and get Citicoline moving. But given the screw up with Redux, and the weak clinical test results, I doubt the FDA will do anything without seen further testing and I doubt any of this will be ready before late 1998. One of the attractives of IPIC for potential and current corporate partners seemed to be the perception of IPIC being very good at getting drugs approved. Otherwise, why not sponsor the clinical research themselves instead of sharing with IPIC? after all they already have the drug(s). In addition some of the partners, Lilly, Merck, etc. may decide not to continue having the name of their companies/drug(s) associated with the "makers of Redux" and thus cancell their contracts. Thanks to all of you for your helpful input.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next